Learn More
Overdiagnosis of Parkinson's disease (PD) is suggested by specialist review of community diagnosis, and in postmortem studies. In specialist centers 4 to 15% of patients entered into clinical trials(More)
Complementing clinical findings with those generated by biomarkers—such as β-amyloid-targeted positron emission tomography (PET) imaging—has been proposed as a means of increasing overall accuracy in(More)